SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

McMasters David

(Last)

(First)

(Middle)

PO BOX 2480

(Street)

NORTH BEND

98045

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/31/2008

3. Issuer Name and Ticker or Trading Symbol
ANGIOTECH PHARMACEUTICALS INC [ ANPI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Sr VP Legal & General Counsel

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	800	D
Common stock	2,000	I	by Spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	11/01/2000⁽¹⁾	10/18/2010	Common Stock	700,000	$17.5	D
Options	12/01/2001⁽²⁾	12/06/2011	Common Stock	120,000	$21.388	D
Awards	12/01/2002⁽³⁾	12/17/2012	Common Stock	50,000	$13.468	D
Awards	12/01/2003⁽⁴⁾	01/21/2009	Common Stock	60,000	$31.85	D
Awards	12/01/2003⁽⁵⁾	12/01/2010	Common Stock	60,000	$17.41	D
Awards	03/01/2007⁽⁶⁾	02/04/2012	Common Stock	175,000	$7.65	D

Explanation of Responses:

1. The option is currently exercisable as to all 700000 shares. The option became exercisable on 11/1/2000 having vested in 48 equal installments over four years with the last installment vesting on 10/1/2004.

2. The option is currently exercisable as to all 120000 shares. The option became exercisable on 12/1/2001 having vested in 48 equal installments over four years with the last installment vesting on 11/1/2005.

3. The option is currently exercisable as to all 50000 shares. The option became exercisable on 12/1/2002 having vested in 48 equal installments over four years with the last installment vesting on 11/1/2006.

4. The option is currently exercisable as to all 60000 shares. The option became exercisable on 12/1/2003 having vested in 48 equal installments over four years with the last installment vesting on 12/1/2007.

5. The option is currently exercisable as to all 60000 shares. The option became exercisable on 12/1/2003 having vested in 48 equal installments over four years with the last installment vesting on 12/1/2007.

6. The option is currently exercisable as to all 47396 shares. The option became exercisable on 3/1/2007 and will continue to vest with respect to the remaining 127604 shares in equal installments on a monthly basis until 2/1/2011.

Remarks:

(1)-(5) Conversion or Exercise Prices are in Canadian funds; (6) is in US Funds

	/s/ David McMasters	04/10/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.